On September 15th, 2013, BioTD and BIODIS, a Little Rock, Arkansas based company entered into an agreement to distribute CITOFEM distribute Citofem®, in North America, India, Africa and Asia.
“Citofem® is the next generation of liquid cytology,” said Dr. Ladly Abraham, Chief Medical Officer ofBiodis. “Citofem® requires no specialized machinery, and offers the greatest value in cervical cancer screening in the world today.”
“With the talent, passion and experience Biodis has for distributing superior products and providing quick, responsive service, we believe Biodis is the ideal partner to assist us in the sales and distribution of Citofem® worldwide,” said Robin Wiscovitch, CEO, BioTD. S.A.